Kaufmann Gunnar F. 4
4 · Oncternal Therapeutics, Inc. · Filed Jan 5, 2023
Insider Transaction Report
Form 4
Kaufmann Gunnar F.
Chief Scientific Officer
Transactions
- Tax Payment
Common Stock
2023-01-03$1.02/sh−6,266$6,391→ 66,726 total
Footnotes (1)
- [F1]Shares withheld by the Issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units.